BIJUVA®, le seul THS bioidentique, combinant estradiol et progestérone dans une seule pilule: enfin disponible en Belgique, après les EU (approbation en 2018 par la Food and Drug Administration) !

Bijuva® is intended for the « natural» treatment of estrogen deficiency symptoms. It combines the two bioidentical female hormones (progesterone P4 and estradiol E2) in low doses into a single capsule. It is taken in the evening, promoting falling asleep and improving sleep disorders. The phase 3 trial, REPLENISH, randomized double-blind versus placebo-controlled, demonstrated good effectiveness on vasomotor symptoms and quality of life, as well as, over one year, its endometrial safety (no endometrial hyperplasia). Bijuva® is a non-stop continuous combination drug that minimizes blood loss an... Mehr ...

Verfasser: L'Hermite, Marc
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Schlagwörter: Sciences bio-médicales et agricoles / bioidentical hormones / endometrial hyperplasia / estradiol / hormone replacement treatment (HRT) / progesterone
Sprache: Französisch
Permalink: https://search.fid-benelux.de/Record/base-27336615
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/346884